Article
Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.
The oncologist - 1 Jan 2012
Nicoletti Paola, Cartsos Vassiliki M, Palaska Penelope K, Shen Yufeng, Floratos Aris, Zavras Athanasios I
Abstract excerpt
UNLABELLED: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious adverse drug reaction. We conducted a genomewide association study to search for genetic variants with a large effect size that increase the risk for BRONJ. METHODS: We ascertained BRONJ cases according to the diagnostic criteria of the American Association of Oral and Maxillofacial Surgeons. We genotyped cases and a set of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
